 Kathleen Waugh
Concepts (146)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Islets of Langerhans | 11 | 2025 | 791 | 1.420 |
Why?
| | Diabetes Mellitus, Type 1 | 23 | 2025 | 3629 | 1.320 |
Why?
| | Autoantibodies | 19 | 2025 | 1468 | 1.160 |
Why?
| | Autoimmunity | 13 | 2023 | 863 | 0.870 |
Why?
| | Celiac Disease | 6 | 2022 | 286 | 0.800 |
Why?
| | Transglutaminases | 4 | 2021 | 153 | 0.360 |
Why?
| | Luminescent Measurements | 3 | 2021 | 76 | 0.350 |
Why?
| | Mass Screening | 6 | 2021 | 1192 | 0.350 |
Why?
| | Glutens | 2 | 2019 | 57 | 0.310 |
Why?
| | Epitopes | 3 | 2025 | 474 | 0.290 |
Why?
| | Child | 24 | 2025 | 20882 | 0.280 |
Why?
| | Inflammation | 1 | 2017 | 2748 | 0.250 |
Why?
| | Blood Proteins | 2 | 2017 | 245 | 0.240 |
Why?
| | Receptor-Like Protein Tyrosine Phosphatases, Class 8 | 1 | 2025 | 63 | 0.230 |
Why?
| | Infant | 12 | 2022 | 8987 | 0.230 |
Why?
| | CD4-Positive T-Lymphocytes | 3 | 2025 | 1058 | 0.220 |
Why?
| | Child, Preschool | 13 | 2025 | 10487 | 0.220 |
Why?
| | Electrochemical Techniques | 2 | 2021 | 48 | 0.210 |
Why?
| | Peptide Library | 1 | 2024 | 84 | 0.210 |
Why?
| | GTP-Binding Proteins | 2 | 2021 | 158 | 0.210 |
Why?
| | Insulin | 2 | 2025 | 2329 | 0.200 |
Why?
| | Bacteriophages | 1 | 2024 | 86 | 0.200 |
Why?
| | Autoantigens | 2 | 2025 | 420 | 0.190 |
Why?
| | Disease Progression | 8 | 2022 | 2628 | 0.190 |
Why?
| | Zinc Transporter 8 | 1 | 2021 | 87 | 0.180 |
Why?
| | Insulins | 1 | 2022 | 37 | 0.180 |
Why?
| | Oxylipins | 1 | 2020 | 33 | 0.170 |
Why?
| | T-Lymphocytes | 2 | 2025 | 1937 | 0.160 |
Why?
| | Virus Diseases | 1 | 2021 | 210 | 0.160 |
Why?
| | Peptides | 2 | 2024 | 926 | 0.160 |
Why?
| | Adolescent | 14 | 2025 | 20415 | 0.160 |
Why?
| | Humans | 31 | 2025 | 129687 | 0.150 |
Why?
| | Male | 21 | 2025 | 63691 | 0.150 |
Why?
| | Dietary Proteins | 1 | 2019 | 129 | 0.150 |
Why?
| | Genetic Predisposition to Disease | 3 | 2022 | 2271 | 0.140 |
Why?
| | High-Throughput Screening Assays | 1 | 2019 | 139 | 0.140 |
Why?
| | Genotype | 2 | 2020 | 1829 | 0.140 |
Why?
| | Interferon-gamma | 1 | 2021 | 773 | 0.140 |
Why?
| | Female | 20 | 2025 | 68751 | 0.140 |
Why?
| | Health Care Costs | 1 | 2020 | 367 | 0.130 |
Why?
| | Influenza, Human | 1 | 2022 | 602 | 0.130 |
Why?
| | Eating | 1 | 2019 | 371 | 0.130 |
Why?
| | Autoimmune Diseases | 1 | 2019 | 428 | 0.120 |
Why?
| | DNA Methylation | 1 | 2020 | 606 | 0.120 |
Why?
| | Prospective Studies | 6 | 2023 | 7145 | 0.120 |
Why?
| | Pediatrics | 2 | 2020 | 1056 | 0.110 |
Why?
| | Follow-Up Studies | 5 | 2021 | 4892 | 0.110 |
Why?
| | Biomarkers | 3 | 2021 | 3969 | 0.100 |
Why?
| | Case-Control Studies | 2 | 2020 | 3381 | 0.100 |
Why?
| | Proteome | 1 | 2016 | 440 | 0.100 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2016 | 820 | 0.090 |
Why?
| | Diet | 1 | 2019 | 1212 | 0.090 |
Why?
| | Toll-Like Receptors | 1 | 2012 | 179 | 0.090 |
Why?
| | Cytokines | 2 | 2017 | 2022 | 0.090 |
Why?
| | Oxidative Stress | 1 | 2017 | 1264 | 0.090 |
Why?
| | Sensitivity and Specificity | 3 | 2022 | 1844 | 0.090 |
Why?
| | Gene Expression Profiling | 1 | 2017 | 1686 | 0.090 |
Why?
| | Interleukin-1beta | 1 | 2012 | 369 | 0.080 |
Why?
| | Risk Factors | 5 | 2023 | 9787 | 0.080 |
Why?
| | Insulin Antibodies | 2 | 2022 | 105 | 0.080 |
Why?
| | Young Adult | 5 | 2025 | 12457 | 0.080 |
Why?
| | Interleukin-6 | 1 | 2012 | 724 | 0.070 |
Why?
| | Adult | 7 | 2025 | 35607 | 0.060 |
Why?
| | Prognosis | 3 | 2021 | 3772 | 0.060 |
Why?
| | Proportional Hazards Models | 2 | 2019 | 1199 | 0.060 |
Why?
| | C-Peptide | 1 | 2025 | 163 | 0.060 |
Why?
| | Epitope Mapping | 1 | 2024 | 58 | 0.050 |
Why?
| | Glycomics | 1 | 2022 | 7 | 0.050 |
Why?
| | Ascorbic Acid | 1 | 2023 | 120 | 0.050 |
Why?
| | Protein Processing, Post-Translational | 1 | 2025 | 457 | 0.050 |
Why?
| | Polysaccharides | 1 | 2022 | 86 | 0.050 |
Why?
| | Longitudinal Studies | 2 | 2020 | 2724 | 0.050 |
Why?
| | Antibodies | 1 | 2024 | 399 | 0.050 |
Why?
| | Electrochemistry | 1 | 2021 | 79 | 0.050 |
Why?
| | Sciatic Nerve | 1 | 2002 | 56 | 0.050 |
Why?
| | Lipoprotein Lipase | 1 | 2002 | 59 | 0.050 |
Why?
| | Diagnostic Techniques, Radioisotope | 1 | 2021 | 9 | 0.040 |
Why?
| | China | 1 | 2021 | 192 | 0.040 |
Why?
| | Immunoglobulin D | 1 | 2021 | 29 | 0.040 |
Why?
| | Antigens, Viral | 1 | 2021 | 179 | 0.040 |
Why?
| | Serologic Tests | 1 | 2021 | 52 | 0.040 |
Why?
| | Receptors, Antigen, T-Cell, alpha-beta | 1 | 2022 | 336 | 0.040 |
Why?
| | Proteomics | 2 | 2017 | 1058 | 0.040 |
Why?
| | Asymptomatic Diseases | 1 | 2021 | 84 | 0.040 |
Why?
| | Fatty Acids, Omega-6 | 1 | 2020 | 47 | 0.040 |
Why?
| | Myelin Sheath | 1 | 2002 | 160 | 0.040 |
Why?
| | Amino Acid Sequence | 1 | 2024 | 2057 | 0.040 |
Why?
| | Whole Genome Sequencing | 1 | 2020 | 128 | 0.040 |
Why?
| | Quality-Adjusted Life Years | 1 | 2020 | 106 | 0.040 |
Why?
| | Immunoglobulin M | 1 | 2021 | 276 | 0.040 |
Why?
| | Immunoglobulin A | 1 | 2021 | 201 | 0.040 |
Why?
| | Costs and Cost Analysis | 1 | 2020 | 201 | 0.040 |
Why?
| | Immunoglobulin E | 1 | 2021 | 330 | 0.040 |
Why?
| | Middle Aged | 4 | 2025 | 31165 | 0.040 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2022 | 486 | 0.040 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2020 | 138 | 0.040 |
Why?
| | Early Diagnosis | 1 | 2020 | 233 | 0.040 |
Why?
| | Cross-Sectional Studies | 2 | 2022 | 5083 | 0.040 |
Why?
| | Diet Surveys | 1 | 2019 | 92 | 0.040 |
Why?
| | Disease Susceptibility | 1 | 2020 | 334 | 0.040 |
Why?
| | Receptors, Antigen, T-Cell | 1 | 2022 | 707 | 0.040 |
Why?
| | Antibodies, Viral | 1 | 2021 | 602 | 0.040 |
Why?
| | Population Surveillance | 1 | 2020 | 439 | 0.030 |
Why?
| | Diabetic Ketoacidosis | 1 | 2020 | 197 | 0.030 |
Why?
| | Cost-Benefit Analysis | 1 | 2020 | 569 | 0.030 |
Why?
| | Radioimmunoassay | 1 | 2016 | 175 | 0.030 |
Why?
| | Calcium | 1 | 2023 | 1212 | 0.030 |
Why?
| | Disease Management | 1 | 2020 | 588 | 0.030 |
Why?
| | Glucose Tolerance Test | 1 | 2018 | 355 | 0.030 |
Why?
| | Immunity, Innate | 1 | 2022 | 804 | 0.030 |
Why?
| | Immunoglobulin G | 1 | 2021 | 851 | 0.030 |
Why?
| | Insulin-Secreting Cells | 1 | 2021 | 367 | 0.030 |
Why?
| | Glutamate Decarboxylase | 1 | 2016 | 166 | 0.030 |
Why?
| | C-Reactive Protein | 1 | 2018 | 401 | 0.030 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2020 | 576 | 0.030 |
Why?
| | HLA-DR Antigens | 1 | 2016 | 223 | 0.030 |
Why?
| | Epigenesis, Genetic | 1 | 2020 | 615 | 0.030 |
Why?
| | Incidence | 1 | 2021 | 2644 | 0.030 |
Why?
| | Macrophages | 1 | 2002 | 1489 | 0.030 |
Why?
| | Biopsy | 1 | 2016 | 1087 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2018 | 1950 | 0.020 |
Why?
| | Multivariate Analysis | 1 | 2016 | 1500 | 0.020 |
Why?
| | Body Mass Index | 1 | 2020 | 2274 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2019 | 3084 | 0.020 |
Why?
| | Feasibility Studies | 1 | 2015 | 869 | 0.020 |
Why?
| | Risk Assessment | 1 | 2020 | 3260 | 0.020 |
Why?
| | Hypoglycemic Agents | 1 | 2020 | 1220 | 0.020 |
Why?
| | Cohort Studies | 1 | 2021 | 5434 | 0.020 |
Why?
| | Transcriptome | 1 | 2016 | 875 | 0.020 |
Why?
| | Exercise | 1 | 2022 | 1933 | 0.020 |
Why?
| | Colorado | 1 | 2020 | 4405 | 0.020 |
Why?
| | Leukocytes, Mononuclear | 1 | 2012 | 546 | 0.020 |
Why?
| | Age Factors | 1 | 2016 | 3153 | 0.020 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2022 | 2443 | 0.020 |
Why?
| | Time Factors | 1 | 2017 | 6545 | 0.020 |
Why?
| | Mice | 1 | 2022 | 16982 | 0.020 |
Why?
| | United States | 1 | 2021 | 13906 | 0.010 |
Why?
| | Animals | 2 | 2022 | 35404 | 0.010 |
Why?
| | Aged | 1 | 2021 | 22101 | 0.010 |
Why?
| | Nerve Crush | 1 | 2002 | 5 | 0.010 |
Why?
| | Peripheral Nerves | 1 | 2002 | 69 | 0.010 |
Why?
| | Signal Transduction | 1 | 2012 | 4935 | 0.010 |
Why?
| | Immunohistochemistry | 1 | 2002 | 1690 | 0.010 |
Why?
| | Rats, Sprague-Dawley | 1 | 2002 | 2403 | 0.010 |
Why?
| | RNA, Messenger | 1 | 2002 | 2702 | 0.010 |
Why?
| | Rats | 1 | 2002 | 5485 | 0.010 |
Why?
|
|
Waugh's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|